1644 related articles for article (PubMed ID: 17544323)
1. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
[TBL] [Abstract][Full Text] [Related]
2. Restless legs syndrome in end-stage renal disease.
Gigli GL; Adorati M; Dolso P; Piani A; Valente M; Brotini S; Budai R
Sleep Med; 2004 May; 5(3):309-15. PubMed ID: 15165541
[TBL] [Abstract][Full Text] [Related]
3. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels.
Frauscher B; Gschliesser V; Brandauer E; El-Demerdash E; Kaneider M; Rücker L; Poewe W; Högl B
Sleep Med; 2009 Jun; 10(6):611-5. PubMed ID: 19200780
[TBL] [Abstract][Full Text] [Related]
4. Validation of an algorithm for the diagnosis of Restless Legs Syndrome: The Restless Legs Syndrome-Diagnostic Index (RLS-DI).
Benes H; Kohnen R
Sleep Med; 2009 May; 10(5):515-23. PubMed ID: 18823819
[TBL] [Abstract][Full Text] [Related]
5. Augmentation as a treatment complication of restless legs syndrome: concept and management.
García-Borreguero D; Allen RP; Benes H; Earley C; Happe S; Högl B; Kohnen R; Paulus W; Rye D; Winkelmann J
Mov Disord; 2007; 22 Suppl 18():S476-84. PubMed ID: 17580331
[TBL] [Abstract][Full Text] [Related]
6. Empirical evaluation of the accuracy of diagnostic criteria for Restless Legs Syndrome.
Benes H; von Eye A; Kohnen R
Sleep Med; 2009 May; 10(5):524-30. PubMed ID: 18996741
[TBL] [Abstract][Full Text] [Related]
7. [Restless legs syndrome in patients on dialysis for kidney insufficiency: effect of medication].
Hohl-Radke F; Aedtner F; Domröse U; Neumann KH; Staedt J
Dtsch Med Wochenschr; 2008 Jan; 133(3):71-5. PubMed ID: 18186007
[TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic augmentation of restless legs syndrome.
García-Borreguero D; Williams AM
Sleep Med Rev; 2010 Oct; 14(5):339-46. PubMed ID: 20219397
[TBL] [Abstract][Full Text] [Related]
10. Assessment of restless legs syndrome--methodological approaches for use in practice and clinical trials.
Kohnen R; Allen RP; Benes H; Garcia-Borreguero D; Hening WA; Stiasny-Kolster K; Zucconi M
Mov Disord; 2007; 22 Suppl 18():S485-94. PubMed ID: 17534967
[TBL] [Abstract][Full Text] [Related]
11. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.
Allen RP; Picchietti DL; Garcia-Borreguero D; Ondo WG; Walters AS; Winkelman JW; Zucconi M; Ferri R; Trenkwalder C; Lee HB;
Sleep Med; 2014 Aug; 15(8):860-73. PubMed ID: 25023924
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome.
García-Borreguero D; Kohnen R; Högl B; Ferini-Strambi L; Hadjigeorgiou GM; Hornyak M; de Weerd AW; Happe S; Stiasny-Kolster K; Gschliesser V; Egatz R; Cabrero B; Frauscher B; Trenkwalder C; Hening WA; Allen RP
Sleep Med; 2007 Aug; 8(5):455-63. PubMed ID: 17543579
[TBL] [Abstract][Full Text] [Related]
13. [Restless legs syndrome].
Lai SC; Chen RS
Acta Neurol Taiwan; 2008 Mar; 17(1):54-65. PubMed ID: 18564830
[TBL] [Abstract][Full Text] [Related]
14. Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics.
Benes H; Walters AS; Allen RP; Hening WA; Kohnen R
Mov Disord; 2007; 22 Suppl 18():S401-8. PubMed ID: 17566118
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment of restless legs syndrome with dopamine agonists.
Ondo W; Romanyshyn J; Vuong KD; Lai D
Arch Neurol; 2004 Sep; 61(9):1393-7. PubMed ID: 15364685
[TBL] [Abstract][Full Text] [Related]
16. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
Fulda S; Wetter TC
Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
[TBL] [Abstract][Full Text] [Related]
17. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic indicators of restless legs syndrome in primary care consultations: the DESYR study.
Crochard A; El Hasnaoui A; Pouchain D; Huas D; Arnulf I; Krieger J; Lainey E; Le Jeunne P; Leger D; Schuck S; Texier N; Tison F; Montplaisir J
Mov Disord; 2007 Apr; 22(6):791-7; quiz 907. PubMed ID: 17230475
[TBL] [Abstract][Full Text] [Related]
19. Early manifestations of restless legs syndrome in childhood and adolescence.
Picchietti DL; Stevens HE
Sleep Med; 2008 Oct; 9(7):770-81. PubMed ID: 18024165
[TBL] [Abstract][Full Text] [Related]
20. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group.
Walters AS
Mov Disord; 1995 Sep; 10(5):634-42. PubMed ID: 8552117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
